Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
An open-labe, multicenter, phase II single arm trial of osimertinib in NSCLC patients with uncommon EGFR mutation (KCSG-LU15-09)An open-labe, multicenter, phase II single arm trial of osimertinib in NSCLC patients with uncommon EGFR mutation (KCSG-LU15-09)
- Alternative Title
- An open-labe, multicenter, phase II single arm trial of osimertinib in NSCLC patients with uncommon EGFR mutation (KCSG-LU15-09)
- Authors
- Kang Eun Joo
- Issue Date
- 25-Sep-2018
- Publisher
- IASLC
- Citation
- IASLC 19th World Conference on Lung Cancer
- Conference Name
- IASLC 19th World Conference on Lung Cancer
- Place
- CN
- Conference Date
- 2018-09-23
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.